Skip to main content

Apellis Pharmaceuticals, Inc.

APLSDelisted May 14, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001492422

Apellis Pharmaceuticals, Inc. was delisted on May 14, 2026; its insiders filed their last Form 4 on May 14, 2026; 325 institutions reported holding it in 13F filings for Q1 2026, worth $5.56B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q3 2026

Institutional positions in Apellis Pharmaceuticals, Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

APLS is no longer listed, and 13F filings after Q1 2026 list far fewer holders. See Q1 2026

Institutional holders
0
−1 vs. Q2 2026
Shares held
0
−248 (−100.0%) vs. Q2 2026
Total value
$0
−$10.2K (−100.0%) vs. Q2 2026
New holders
0
0 more added
Sold out
1
0 more reduced

Compare with Q2 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting APLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2026: 0 institutions
Q1 2021: 175 institutionsQ2 2021: 205 institutionsQ3 2021: 181 institutionsQ4 2021: 187 institutionsQ1 2022: 212 institutionsQ2 2022: 212 institutionsQ3 2022: 250 institutionsQ4 2022: 244 institutionsQ1 2023: 282 institutionsQ2 2023: 317 institutionsQ3 2023: 256 institutionsQ4 2023: 284 institutionsQ1 2024: 302 institutionsQ2 2024: 263 institutionsQ3 2024: 267 institutionsQ4 2024: 260 institutionsQ1 2025: 255 institutionsQ2 2025: 247 institutionsQ3 2025: 274 institutionsQ4 2025: 281 institutionsQ1 2026: 325 institutionsQ2 2026: 1 institutionQ3 2026: 0 institutions
Value heldQ3 2026: $0
Q1 2021: $2.80BQ2 2021: $4.08BQ3 2021: $2.29BQ4 2021: $3.83BQ1 2022: $4.62BQ2 2022: $4.15BQ3 2022: $6.66BQ4 2022: $5.20BQ1 2023: $7.28BQ2 2023: $9.71BQ3 2023: $4.34BQ4 2023: $6.82BQ1 2024: $6.65BQ2 2024: $4.43BQ3 2024: $3.41BQ4 2024: $4.04BQ1 2025: $2.80BQ2 2025: $2.28BQ3 2025: $2.80BQ4 2025: $3.17BQ1 2026: $5.56BQ2 2026: $10.2KQ3 2026: $0
Institutions holding APLS and their total value by quarter
QuarterHoldersValue
Q3 20260$0
Q2 20261$10.2K
Q1 2026325$5.56B
Q4 2025281$3.17B
Q3 2025274$2.80B
Q2 2025247$2.28B
Q1 2025255$2.80B
Q4 2024260$4.04B
Q3 2024267$3.41B
Q2 2024263$4.43B
Q1 2024302$6.65B
Q4 2023284$6.82B
Q3 2023256$4.34B
Q2 2023317$9.71B
Q1 2023282$7.28B
Q4 2022244$5.20B
Q3 2022250$6.66B
Q2 2022212$4.15B
Q1 2022212$4.62B
Q4 2021187$3.83B
Q3 2021181$2.29B
Q2 2021205$4.08B
Q1 2021175$2.80B

Institutions, Q3 2026

Shares, value and share of portfolio for each institution holding Apellis Pharmaceuticals, Inc.; share changes are against Q2 2026.

Institutions holding APLS in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
IFP Advisors, Inc0$00.00%−248−100.0%Sold out